PT Metro Healthcare Indonesia Tbk reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was IDR 172,531.92 million compared to IDR 233,313.1 million a year ago. Net loss was IDR 79,864.27 million compared to net income of IDR 18,655.32 million a year ago.

Basic loss per share from continuing operations was IDR 2.402 compared to basic earnings per share from continuing operations of IDR 0.561 a year ago.